Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
July 31, 2026 -0.772M
April 30, 2026 -0.928M
January 31, 2026 -0.668M
October 31, 2025 -1.57M
July 31, 2025 -0.771M
April 30, 2025 -0.516M
January 31, 2025 -29.42M
October 31, 2024 -0.683M
July 31, 2024 -0.278M
April 30, 2024 -0.979M
January 31, 2024 -0.475M
October 31, 2023 -1.265M
July 31, 2023 -1.654M
April 30, 2023 -2.586M
January 31, 2023 -0.643M
October 31, 2022 -0.529M
July 31, 2022 -0.39M
April 30, 2022 -0.686M
January 31, 2022 -0.292M
October 31, 2021 -0.446M
July 31, 2021 -0.484M
April 30, 2021 -0.453M
January 31, 2021 -0.652M
October 31, 2020 -0.37M
July 31, 2020 -0.922M
Date Value
April 30, 2020 -1.094M
January 31, 2020 -0.656M
October 31, 2019 0.468M
July 31, 2019 -1.183M
April 30, 2019 -1.923M
January 31, 2019 -0.979M
October 31, 2018 -0.701M
July 31, 2018 -0.61M
April 30, 2018 -1.488M
January 31, 2018 -0.47M
October 31, 2017 -1.002M
July 31, 2017 -0.435M
April 30, 2017 -0.421M
January 31, 2017 -0.428M
October 31, 2016 -0.706M
July 31, 2016 -1.056M
April 30, 2016 -0.479M
January 31, 2016 -0.447M
October 31, 2015 -1.101M
July 31, 2015 -0.16M
April 30, 2015 -0.185M
January 31, 2015 -0.164M
October 31, 2014 -1.618M
July 31, 2014 -2.509M
April 30, 2014 -0.098M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Enovis Corp. -45.01M
Edwards Lifesciences Corp. -193.20M
Intuitive Surgical, Inc. -26.60M
STAAR Surgical Co. -1.366M
Stryker Corp. -639.00M